![]() |
![]()
|
Trends in Bio/Pharmaceutical Industry
Letter from Editor
Triumphal return of haigui: IPo of Wuxi PharmaTech in us The Keys to Ge li and Wuxi PharmaTechs success Made-in-China: FDA Approved First Generic Drug from China
Ready for Primetime in us? an Overview of the Regulatory and Patent Environment for Follow-on Biologics 2006年中国中药资源研究与学科建设进展
Label Free Technology for Drug Research Development of Hepatitis B Therapeutic Vaccine
|
|
|
|---|